Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GRM5: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | GRM5 |
| Aliases | Page for GRM5 Gene |
| Protein Type | Receptor |
| Function | mGluR5 mediates modulatory glutamate signaling |
| Subcellular Localization | Plasma membrane, Dendritic spines |
| Molecular Weight | 132 kDa |
| Exons | 10 |
| Pathways | MAPK |
| UniProt ID | [P41594](https://www.uniprot.org/uniprot/P41594) |
| GeneCards | GRM5 |
| Human Protein Atlas | GRM5 |
| Associated Diseases | Alzheimer, Autism, Bipolar, Cancer, Inflammation, Ms |
| Interactions | CACNA1B, CACNA1H, CDK5R2, DRD1, DRD2, FGF13 |
| KG Connections | 119 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
GRM5["GRM5"]
Ms{"Ms"}
GRM5 -->|"associated with"| Ms
Schizophrenia{"Schizophrenia"}
GRM5 -->|"associated with"| Schizophrenia
GABARAP["GABARAP"]
GRM5 -->|"associated with"| GABARAP
GABRB1["GABRB1"]
GRM5 -->|"associated with"| GABRB1
Toll_Like_Receptor(["Toll-Like Receptor"])
GRM5 -->|"associated with"| Toll_Like_Receptor
neurodegeneration["neurodegeneration"]
GRM5 -->|"implicated in"| neurodegeneration
style GRM5 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Autism | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Bipolar | associated_with | disease | 0.65 |
| Encephalitis | therapeutic_target | disease | 0.65 |
| Schizophrenia | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| SCN8A | targets | gene | 0.60 |
| STAT1 | targets | gene | 0.60 |
| SCN2B | targets | gene | 0.60 |
| ISG15 | targets | gene | 0.60 |
| SLC17A7 | targets | gene | 0.60 |
| HTR2C | interacts_with | gene | 0.60 |
| GRIK4 | associated_with | gene | 0.60 |
| CACNA1B | associated_with | gene | 0.60 |
| ISG15 | interacts_with | gene | 0.60 |
| SCN2B | interacts_with | gene | 0.60 |
| SCN8A | interacts_with | gene | 0.60 |
| STAT1 | interacts_with | gene | 0.60 |
| FGF13 | therapeutic_target | gene | 0.60 |
| CDK5R2 | therapeutic_target | gene | 0.60 |
| Toll-Like Receptor | associated_with | pathway | 0.60 |
| Interferon | therapeutic_target | protein | 0.60 |
| Cdk5 | therapeutic_target | protein | 0.60 |
| DRD1 | associated_with | gene | 0.60 |
| Rb | associated_with | protein | 0.60 |
| ISG15 | associated_with | gene | 0.60 |
| SCN2B | associated_with | gene | 0.60 |
| SCN8A | associated_with | gene | 0.60 |
| STAT1 | associated_with | gene | 0.60 |
| Interferon Signaling | therapeutic_target | pathway | 0.60 |
| App | therapeutic_target | protein | 0.60 |
| Fgf | therapeutic_target | protein | 0.60 |
| GABAergic neurons | expressed_in | cell_type | 0.60 |
| SLC1A1 | associated_with | gene | 0.60 |
| GRIA1 | associated_with | gene | 0.60 |
| SLC6A2 | associated_with | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| PARKINSON'S DISEASE | associated_with | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| Dopaminergic | associated_with | cell_type | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| GABARAP | associated_with | gene | 0.60 |
| GABRB1 | associated_with | gene | 0.60 |
| HTR2A | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GENES | associated_with | gene | 0.60 |
| INFLAMMATION | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| HUB GENES | associated_with | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| FGF13 | targets | gene | 0.60 |
| CDK5R2 | targets | gene | 0.60 |
| GRIK4 | interacts_with | gene | 0.60 |
| CDK5R2 | interacts_with | gene | 0.60 |
| FGF13 | interacts_with | gene | 0.60 |
| CACNA1H | interacts_with | gene | 0.60 |
| GABRB2 | interacts_with | gene | 0.60 |
| GRIA1 | interacts_with | gene | 0.60 |
| ISG15 | therapeutic_target | gene | 0.60 |
| GABRB2 | associated_with | gene | 0.60 |
| SLC1A1 | associated_with | gene | 0.60 |
| SLC6A2 | associated_with | gene | 0.60 |
| GRIK4 | associated_with | gene | 0.60 |
| GRIA1 | associated_with | gene | 0.60 |
| DRD1 | associated_with | gene | 0.60 |
| CACNA1B | associated_with | gene | 0.60 |
| SCN2B | associated_with | gene | 0.60 |
| STAT1 | associated_with | gene | 0.60 |
| ISG15 | associated_with | gene | 0.60 |
| SCN8A | associated_with | gene | 0.60 |
| FGF13 | associated_with | gene | 0.60 |
| SLC17A7 | associated_with | gene | 0.60 |
| CDK5R2 | associated_with | gene | 0.60 |
| HTR2A | associated_with | gene | 0.60 |
| STAT1 | therapeutic_target | gene | 0.60 |
| SCN8A | therapeutic_target | gene | 0.60 |
| SLC17A7 | therapeutic_target | gene | 0.60 |
| CACNA1H | associated_with | gene | 0.60 |
| DRD2 | associated_with | gene | 0.60 |
| HTR2C | associated_with | gene | 0.60 |
| GABRA1 | associated_with | gene | 0.60 |
| SCN2B | therapeutic_target | gene | 0.60 |
| SCN8A | interacts_with | gene | 0.50 |
| DRD2 | interacts_with | gene | 0.50 |
| HTR2C | interacts_with | gene | 0.50 |
| DRD1 | interacts_with | gene | 0.50 |
| CACNA1B | interacts_with | gene | 0.50 |
| GABRA1 | interacts_with | gene | 0.50 |
| ISG15 | interacts_with | gene | 0.50 |
| STAT1 | interacts_with | gene | 0.50 |
| SCN2B | interacts_with | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning GRM5 in their description or question text
No additional research found